Guerbet is a global specialist in contrast media and solutions for diagnostic and interventional radiology. Guerbet’ strategy to strengthen Interventional Imaging has already been in place for several years and is continuing.

The company is particularly involved in liver cancer treatment as well as vascular anomalies embolization with its product 利博多^® Ultra Fluid and by developing innovative delivery solutions.

The mission of Guerbet Interventional Imaging franchise is to provide interventional medical community with innovative image-guided solutions to help physicians advance their patients treatments & outcomes.